Malaria: all 1,315 studies
Page 4 of 14. Open to participants first (86), then studies with results posted, then the rest; newest registration first within each.
- MaCRA Part B in Côte d'IvoireWithdrawnNCT06804902Not applicable
- First-in-Human PfSPZ-LARC2 Vaccination/CHMICompletedNCT06735209Phase 1
- Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina FasoCompletedNCT06652737Phase 1
- Leveraging the Seasonal Malaria Chemoprevention Platform to Address Malaria and MalnutritionActive, not recruitingNCT06599593Not applicable
- Improving Knowledge, Attitudes and Practices for Malaria Prevention in the Embera Katio PopulationCompletedNCT06590597Not applicable
- Vivax Elimination With Tafenoquine (VET) StudyCompletedNCT06575647Phase 4
- Performance of an Ultrasensible Malaria Rapid Diagnostic Test Among Pregnant Women in Burkina FasoCompletedNCT06572644
- Evaluation of a Comprehensive School Health Programme in ZambiaActive, not recruitingNCT06560853Not applicable
- Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV371 LAI in Healthy ParticipantsCompletedNCT06558643Phase 1
- Malaria Molecular Surveillance in Mozambique (Phase 2)Active, not recruitingNCT06529237
- Host Immune Dynamics Following Seasonal Malaria Chemoprevention in African ChildrenActive, not recruitingNCT06524336
- Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, EthiopiaActive, not recruitingNCT06516042Phase 3
- Efficacy of Only IV Artesunate Versus IV Artesunate Plus IV Quinine in the Treatment of Severe Malaria in Children: A Comparative StudyCompletedNCT06472258Not applicable
- Study To Evaluate Safety, Tolerability, and Pharmacokinetics of MAM01 in African PopulationCompletedNCT06408857Phase 1
- Efficacy of Focal Primaquine Mass Administration for Eliminating Plasmodium Vivax Malaria in Northern MyanmarActive, not recruitingNCT06392152Not applicable
- Health Education by Buddhist Monks to Promote Malaria Knowledge and Preventive Practices in Rural MyanmarCompletedNCT06386367Not applicable
- Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in LiberiaCompletedNCT06300970Phase 4
- A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003)CompletedNCT06294912Phase 1
- Diabetes, Metabolic Syndrome and Risk of Malaria in CameroonCompletedNCT06278181
- Impact of Differential and Systematic Diagnosis of Dengue, Chikungunya and Malaria on Patient Management and Antibiotic Use in West AfricaCompletedNCT06257810Not applicable
- Evaluation of the Protective Efficacy of a Spatial Repellent to Reduce Malaria Prevalence in UgandaStatus unknownNCT06232954Not applicable
- Clinical Validation of Novel Malaria Diagnostic Tools for POC Point-of-Care TestingCompletedNCT06225700
- Evaluation of Vector and Chemoprevention-based Interventions to Reduce Malaria Burden in Urban Daaras of Touba, SenegalSuspendedNCT06225297Phase 4
- Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected CommunitiesCompletedNCT06179732Phase 3
- Parasite Clearance and Protection from Infection (PCPI) in CameroonCompletedNCT06173206Phase 3
- Parasite Clearance and Protection From Infection (PCPI) in ZambiaCompletedNCT06166498Phase 3
- Perennial Malaria Chemoprevention (PMC) Effect StudyActive, not recruitingNCT06155448Not applicable
- Africa Ready Malaria ScreeningActive, not recruitingNCT06153862Not applicable
- A Study to Compare Two Dosing Regimens for a New Malaria VaccineActive, not recruitingNCT06141057Phase 1
- Spatial Repellents for Malaria ControlWithdrawnNCT06122142Not applicable
- Test Efficacy Study on the Recommended Antimalarial Drugs in the Democratic Republic of the CongoCompletedNCT06076213Phase 4
- Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEXCompletedNCT06064591
- Therapeutic Efficacy of Chloroquine Plus Primaquine in the Treatment of Uncomplicated Plasmodium VivaxCompletedNCT06044805Phase 4
- Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed with Plasmodium FalciparumActive, not recruitingNCT06040346Phase 2
- Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West PapuaCompletedNCT06036030Phase 2
- Comparing Chemoprevention Drugs for School-based Malaria ControlCompletedNCT05980156Phase 4
- A Study to Assess the Safety and Effectiveness of Two Experimental Malaria VaccinesCompletedNCT05978037Phase 1/2
- TES of Artemether-lumefantrine for Pf in the Philippines in 2017-2018CompletedNCT05958810
- TES of Chloroquine for Pv in the Philippines in 2016CompletedNCT05958797
- TES of Artemether-lumefantrine for Pf in the Philippines in 2015CompletedNCT05958693
- LLIN Evaluation in Uganda Project (LLINEUP3)CompletedNCT05950191Not applicable
- Study of the Plasmodium Vivax Transmission-blocking Vaccine Pvs230D1-EPA/Matrix-M to Assess Safety, Immunogenicity, and Transmission-blocking Activity in Healthy Malaria-naive AdultsCompletedNCT05913973Phase 1
- Pan-Malaria Transmission-Blocking Vaccine AnAPN1CompletedNCT05905432Phase 1
- Perennial Malaria Chemoprevention (PMC) in CameroonCompletedNCT05889052
- Understanding and Maximizing the Community Impact of Antimalarial Treatment (INDIE-SMC)CompletedNCT05878366Not applicable
- Dihydroartemisinin-piperaquine for Seasonal Malaria Chemoprophylaxis in TanzaniaCompletedNCT05874869Not applicable
- Perennial Malaria Chemoprevention (PMC) in Côte d'IvoireCompletedNCT05856357
- Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum MalariaCompletedNCT05842954Phase 3
- Momordica Charantia and Dihydroartemisinin-piperaquined-primaquine for Uncomplicated Plasmodium Falciparum Malaria Patients in Southwest Sumba RegencyCompletedNCT05829187Phase 2
- Net Transition Initiative: Efficacy of Two Next-generation Nets for Control of Malaria in Cote d'IvoireActive, not recruitingNCT05796193Not applicable
- MSP3-CRM-Vac4All/ Alhydrogel® VaccineStatus unknownNCT05776017Phase 1/2
- An MRI Ancillary Study of a Malaria Fever InvestigationCompletedNCT05746819
- EaveTubes for Vector ControlActive, not recruitingNCT05736679Not applicable
- Association of Diabetes and Metabolic Syndrome With Severe Malaria in CameroonStatus unknownNCT05685875
- Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)WithdrawnNCT05652504Phase 1
- Impact of Seasonal Malaria Chemoprevention on Immunity Against Malaria Among Children in Northern BeninCompletedNCT05650502
- Assessment of the Malaria Vaccine Candidate SumayaVac-1 in Healthy Adults Aged 18-45 Years Living in a Malaria Endemic CountryCompletedNCT05644067Phase 1
- Ivermectin-artemisinin Combination Therapy for Eradication of MalariaStatus unknownNCT05605925Phase 4
- CHILD (Child Health and Infection With Low Density) MalariaCompletedNCT05567016Not applicable
- Radical CUREfor MAlaria Among Highly Mobile and Hard-to-reach Populations in the Guyanese ShieldCompletedNCT05540470Not applicable
- Malaria Control : Improving Access to Prevention, Diagnostic and Care for Vulnerable Rural CommunitiesStatus unknownNCT05535465Not applicable
- Phenotyping and Genotyping of Duffy AntigenCompletedNCT05527119
- Chemoprevention Efficacy Study in Burkina FasoActive, not recruitingNCT05478954Phase 4
- Effectiveness, Feasibility and Acceptability of Seasonal Malaria Chemoprevention in Aweil South County in South SudanActive, not recruitingNCT05471544Phase 3
- Abbott NxTekTM Malaria RDT WHO Prequalification StudyCompletedNCT05444790
- Emptying Malaria Reservoirs to Accelerate Malaria Elimination in High Transmission SettingsStatus unknownNCT05440773Not applicable
- Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in PregnancyActive, not recruitingNCT05426434Phase 3
- Follow-up of Immunological Pattern and Pregnancy Outcomes in Women Previously Received Placental Malaria VaccineActive, not recruitingNCT05426187
- Permethrin-treated Baby-wraps for the Prevention of Malaria in ChildrenCompletedNCT05391230Not applicable
- Assessment of Safety and Immunogenicity of R21/Matrix-M™ in African Children Living With HIVCompletedNCT05385510Phase 1
- A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of the Blood-stage Malaria Candidate Vaccines RH5.1 in Matrix-M and R78C in Matrix-M in Healthy UK AdultsActive, not recruitingNCT05385471Early Phase 1
- Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African ChildrenStatus unknownNCT05354258Not applicable
- ERASE - Impact of COVID-19 on Malaria ControlStatus unknownNCT05348746
- In Vivo Efficacy of Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in MozambiqueCompletedNCT05343312Phase 4
- Efficacy and Safety of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in CameroonStatus unknownNCT05340153Phase 4
- Drug-drug Interaction Study of Ganaplacide and Lumefantrine With EfavirenzCompletedNCT05330273Phase 1
- Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Karamoja Region, UgandaActive, not recruitingNCT05323721Phase 4
- Evaluating the Clinical Performance and Usability of Novel Malaria RDTs in BrazilStatus unknownNCT05317117Not applicable
- Plasmodium Falciparum Genomic Intelligence in MozambiqueCompletedNCT05306067
- Intermittent Preventive Treatment With Dihydroartemisinin-piperaquine in Papua, IndonesiaCompletedNCT05294406Phase 4
- Performance Evaluation of Malaria Plus Rapid Diagnostic Tests (RDTs) for the Detection of Plasmodium Infections in Patients With Symptoms Suggestive of MalariaCompletedNCT05286359Not applicable
- Comparing Chemoprevention Approaches for School-based Malaria ControlCompletedNCT05244954Phase 4
- Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and DolutegravirCompletedNCT05236530Phase 1
- Primaquine Double Dose for Radical Cure of Plasmodium Vivax in ColombiaWithdrawnNCT05232227Phase 2/3
- Proactive Community Case Management (Pro-CCM) in Rural MadagascarCompletedNCT05223933Not applicable
- Evaluating ATSBs for Malaria Reduction in KenyaCompletedNCT05219565Not applicable
- A Study Of Zy-19489 Administered Via Oral Route To Investigate The Safety, Tolerability And Pharmacokinetics In Healthy Adult Human SubjectsCompletedNCT05206201Phase 1
- MSP3-CRM-Vac4All/ Alhydrogel® Malaria VaccineStatus unknownNCT05197751Phase 1
- Efficacy and Safety of Pyronaridine-Artesunate Versus Artemether-LumefantrineCompletedNCT05192265Phase 2/3
- Effectiveness of Seasonal Malaria Chemoprevention in Nampula Province, Mozambique: Type Two Hybrid Implementation StudyActive, not recruitingNCT05186363Phase 4
- Assessment of Safety and Immunogenicity of a Single Vial Presentation of R21/Matrix-M and Co-Administration With EPI VaccinesCompletedNCT05155579Phase 1
- Trajectories and Mechanisms of Recovery From Malaria: An Observational StudyActive, not recruitingNCT05149157
- Study to Compare Feasibility of 1-step Injectable Artesunate vs. Conventional 2-step Injectable ArtesunateCompletedNCT05140278Phase 2
- Evaluation of Insecticide-treated Eave Nets and Window Screens for Malaria Control in Tanzania.Status unknownNCT05125133Not applicable
- Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Lao PDR and CambodiaStatus unknownNCT05117567Not applicable
- Infections in Migrants in Sweden - the Importance of Malaria and Other Parasitic InfectionsStatus unknownNCT05086887
- MULTIple Doses of IPTi Proposal: a Lifesaving High Yield InterventionCompletedNCT05085340
- RapiGEN BIOCREDIT Malaria Ag RDTs WHO Prequalification StudyCompletedNCT05085301
- Drug-drug Interaction Study of Ganaplacide and Lumefantrine With ItraconazoleCompletedNCT05084651Phase 1
- Monitoring Pregnant Women for Antimalarial Drug ResistanceCompletedNCT05072613